{"filing":{"accession_number":"0001829126-26-010494","cik":"0002109869","ticker":null,"company_name":"Exascale Labs Holdings Inc.","form":"8-K","filing_date":"2026-09-28","report_date":"2026-09-28","primary_document":"exascalelabs_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2109869/000182912626010494/exascalelabs_8k.htm"},"events":[{"id":35508,"run_id":32707,"accession_number":"0001829126-26-010494","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a clear earnings release disclosing fiscal year 2026 financial results for Exascale Labs Holdings Inc. The Item 2.02 section explicitly states \"On September 28, 2026, Exascale Labs Holdings Inc. issued a press release announcing financial results for its fiscal year ended June 30, 2026,\" with the full press release furnished as Exhibit 99.1. The exhibit contains consolidated statements of operations and balance sheets, revenue growth of 111% to $14.8 million, gross profit, operating expenses, and net loss figures—all hallmarks of an earnings release. This is material to investors as it discloses the company's first full-year results as a newly public company (listed on Nasdaq on August 28, 2026).","company_name":"Exascale Labs Holdings Inc.","ticker":null,"filing_date":"2026-09-28","form":"8-K","submitted_at":null,"items":[{"id":39579,"accession_number":"0001829126-26-010494","item_number":"2.02","item_title":"Results of Operations and Financial","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing fiscal year 2026 financial results for Exascale Labs Holdings Inc. The Item 2.02 section explicitly states \"On September 28, 2026, Exascale Labs Holdings Inc. issued a press release announcing financial results for its fiscal year ended June 30, 2026,\" with the full press release furnished as Exhibit 99.1. The exhibit contains consolidated statements of operations and balance sheets, revenue growth of 111% to $14.8 million, gross profit, operating expenses, and net loss figures—all hallmarks of an earnings release. This is material to investors as it discloses the company's first full-year results as a newly public company (listed on Nasdaq on August 28, 2026).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T21:18:44.762069+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39579,"accession_number":"0001829126-26-010494","item_number":"2.02","item_title":"Results of Operations and Financial","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing fiscal year 2026 financial results for Exascale Labs Holdings Inc. The Item 2.02 section explicitly states \"On September 28, 2026, Exascale Labs Holdings Inc. issued a press release announcing financial results for its fiscal year ended June 30, 2026,\" with the full press release furnished as Exhibit 99.1. The exhibit contains consolidated statements of operations and balance sheets, revenue growth of 111% to $14.8 million, gross profit, operating expenses, and net loss figures—all hallmarks of an earnings release. This is material to investors as it discloses the company's first full-year results as a newly public company (listed on Nasdaq on August 28, 2026).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-28T21:18:44.762069+00:00","company_name":"Exascale Labs Holdings Inc.","ticker":null,"filing_date":"2026-09-28"}]}